Seoul, South Korea

Sung-Ig Cho

USPTO Granted Patents = 2 



Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Sung-Ig Cho in Pharmaceutical Composition

Introduction

Sung-Ig Cho is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions for treating degenerative and inflammatory diseases. With a total of two patents to his name, his work is recognized for its potential impact on various health conditions.

Latest Patents

Sung-Ig Cho's latest patents focus on a pharmaceutical composition that is useful for treating or preventing inflammatory diseases and cell damage. The invention utilizes a 2-hydroxybenzoic acid derivative, which is represented by a specific chemical formula or its pharmaceutically acceptable salt. This compound is designed to address a range of inflammatory diseases, including gastritis, gastric ulcer, pancreatitis, colitis, arthritis, diabetes, arteriosclerosis, nephritis, hepatitis, Alzheimer's disease, Parkinson's disease, and Lou Gehrig's disease.

Career Highlights

Sung-Ig Cho is currently associated with Neurotech Pharmaceuticals Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments for complex health issues.

Collaborations

He collaborates with esteemed colleagues, including Byoung-Joo Gwag and Jae-Young Cho, to advance research and development in his field.

Conclusion

Sung-Ig Cho's contributions to pharmaceutical innovations highlight his dedication to improving health outcomes through scientific research. His patents reflect a promising approach to treating serious inflammatory diseases, showcasing the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…